Beijing Konruns Pharmaceutical Co., Ltd. Class ASSE: 603590

Announcement on Implementing Repurchase and Cancellation under 2023 Restricted Stock Incentive Plan

· Issued by Beijing Konruns Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Implementing Repurchase and Cancellation under 2023 Restricted Stock Incentive Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment